Novartis AG (TSX:NVS)

Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CAD 441.63 billion. The enterprise value is 475.86 billion.

Market Cap	441.63B
Enterprise Value	475.86B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Mar 11, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.93%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	36.96%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 23.03 and the forward PE ratio is 19.08.

PE Ratio	23.03
Forward PE	19.08
PS Ratio	5.68
PB Ratio	6.92
P/TBV Ratio	n/a
P/FCF Ratio	18.30
P/OCF Ratio	16.82
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.26, with an EV/FCF ratio of 19.72.

EV / Earnings	24.82
EV / Sales	5.97
EV / EBITDA	14.26
EV / EBIT	17.82
EV / FCF	19.72

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.76.

Current Ratio	1.12
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	1.49
Debt / FCF	2.02
Interest Coverage	16.61

Financial Efficiency

Return on equity (ROE) is 30.81% and return on invested capital (ROIC) is 23.60%.

Return on Equity (ROE)	30.81%
Return on Assets (ROA)	11.14%
Return on Invested Capital (ROIC)	23.60%
Return on Capital Employed (ROCE)	22.71%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.03M
Profits Per Employee	254,743
Employee Count	75,267
Asset Turnover	0.53
Inventory Turnover	2.27

Taxes

In the past 12 months, Novartis AG has paid 3.27 billion in taxes.

Income Tax	3.27B
Effective Tax Rate	14.59%

Stock Price Statistics

The stock price has increased by +35.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+35.20%
50-Day Moving Average	26.87
200-Day Moving Average	n/a
Relative Strength Index (RSI)	72.80
Average Volume (20 Days)	845

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CAD 77.71 billion and earned 19.17 billion in profits. Earnings per share was 9.80.

Revenue	77.71B
Gross Profit	59.03B
Operating Income	26.06B
Pretax Income	22.42B
Net Income	19.17B
EBITDA	32.18B
EBIT	26.06B
Earnings Per Share (EPS)	9.80

Balance Sheet

The company has 15.81 billion in cash and 48.62 billion in debt, with a net cash position of -32.80 billion.

Cash & Cash Equivalents	15.81B
Total Debt	48.62B
Net Cash	-32.80B
Net Cash Per Share	n/a
Equity (Book Value)	63.82B
Book Value Per Share	33.15
Working Capital	4.36B

Cash Flow

In the last 12 months, operating cash flow was 26.25 billion and capital expenditures -2.12 billion, giving a free cash flow of 24.13 billion.

Operating Cash Flow	26.25B
Capital Expenditures	-2.12B
Free Cash Flow	24.13B
FCF Per Share	n/a

Margins

Gross margin is 75.97%, with operating and profit margins of 33.53% and 24.67%.

Gross Margin	75.97%
Operating Margin	33.53%
Pretax Margin	28.85%
Profit Margin	24.67%
EBITDA Margin	41.42%
EBIT Margin	33.53%
FCF Margin	31.05%

Dividends & Yields

This stock pays an annual dividend of 0.53, which amounts to a dividend yield of 1.71%.

Dividend Per Share	0.53
Dividend Yield	1.71%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	55.91%
Buyback Yield	3.93%
Shareholder Yield	5.64%
Earnings Yield	4.34%
FCF Yield	5.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.81 and a Piotroski F-Score of 7.

Altman Z-Score	3.81
Piotroski F-Score	7